Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 7248Neoplasms 4547Prostatic Neoplasms 3494Colorectal Neoplasms 2941Carcinoma, Non-Small-Cell Lung 2832Lung Neoplasms 2548Leukemia, Myeloid, Acute 1983Pancreatic Neoplasms 1875Multiple Myeloma 1812Carcinoma, Hepatocellular 1735Neoplasm Metastasis 1587Stomach Neoplasms 1502Lymphoma 1457Head and Neck Neoplasms 1437Precursor Cell Lymphoblastic Leukemia-Lymphoma 1435Brain Neoplasms 1374Melanoma 1349Ovarian Neoplasms 1347Leukemia 1303Rectal Neoplasms 1270Recurrence 1255Colonic Neoplasms 1204Glioblastoma 1140Uterine Cervical Neoplasms 1098Lymphoma, Non-Hodgkin 1066Leukemia, Lymphocytic, Chronic, B-Cell 989Esophageal Neoplasms 965Lymphoma, Follicular 938Lymphoma, Large B-Cell, Diffuse 933Squamous Cell Carcinoma of Head and Neck 921

Interventions

Radiotherapy 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Interventional × HER2-Negative Locally Advanced Breast Cancer × Clear all
NCT06908668 2025-04-03

Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting
170 enrolled
Breast

HER2-Negative Locally Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡